A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh

Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultana, Arifa, Shahriar, Saimon, Tahsin, Md. Rafat, Mim, Sabiha Rahman, Fatema, Kazi Rubiya, Saha, Ananya, Yesmin, Fahmida, Bahar, Nasiba Binte, Samodder, Mithun, Mamun, Md. Ariful Haque, Aknur Rahman, Md., Ferdousy, Sonia, Akter, Tahmina, Aktar, Fahima, Kuddus, Md. Ruhul, Rahman, Md. Mustafizur, Sarker, Md. Moklesur Rahman, Büyüker, Sultan Mehtap, Chowdhury, Jakir Ahmed, Chowdhury, Abu Asad, Kabir, Shaila, Hossain, Md. Akter, Amran, Md. Shah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538494/
https://www.ncbi.nlm.nih.gov/pubmed/34696198
http://dx.doi.org/10.3390/vaccines9101090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538494/
https://www.ncbi.nlm.nih.gov/pubmed/34696198
http://dx.doi.org/10.3390/vaccines9101090

Ejemplares similares